Professional Summary
Professional Overview
Stuart Poulton is an accomplished biopharmaceutical executive with extensive experience in clinical development, program management, and strategic portfolio leadership. As the Executive Vice President and Chief Development Officer at Karyopharm Therapeutics Inc., he plays a pivotal role in driving the company's clinical development efforts and strategic growth initiatives.
Experience Summary
Current Role
In his current role as Executive Vice President and Chief Development Officer at Karyopharm Therapeutics Inc., Stuart is responsible for leading the company's overall clinical development strategy and operations. He oversees the execution of clinical trials, manages the development pipeline, and collaborates with cross-functional teams to ensure the timely and successful advancement of Karyopharm's oncology and hematology-focused therapeutics.
Career Progression
Prior to joining Karyopharm, Stuart held various leadership positions at renowned pharmaceutical companies, including AbbVie and Amgen. As the Vice President of Clinical Development Operations at AbbVie, he was instrumental in driving the efficient execution of global clinical trials and fostering strong partnerships with external stakeholders. At Amgen, he served as the Executive Director of Global Program Management, where he led the strategic planning and coordination of the company's diverse pipeline of biopharmaceutical products.
Throughout his career, Stuart has demonstrated a strong track record of delivering tangible results and contributing to the advancement of novel therapies. His deep understanding of the pharmaceutical industry, combined with his expertise in program management, clinical operations, and strategic portfolio planning, has enabled him to drive successful drug development initiatives and positively impact patient outcomes.
Academic Background
Stuart holds a Master of Commerce (MCom) degree in Business and Marketing from the University of New South Wales (UNSW) and a Bachelor of Science (BSc) degree in Pharmacology and Chemistry from the University of Sydney.
Areas of Expertise
- Clinical development strategy and operations
- Program and portfolio management
- Cross-functional team leadership
- Pharmaceutical industry regulations and compliance
- Stakeholder management and collaboration
- Strategic planning and business development
Professional Impact
Throughout his career, Stuart has made significant contributions to the pharmaceutical industry. He has successfully led the execution of global clinical trials, optimized operational efficiencies, and steered the advancement of innovative therapies. His strategic leadership and collaborative approach have been instrumental in driving the success of the organizations he has been a part of.
Conclusion
With his extensive industry experience, strong technical expertise, and proven track record of strategic leadership, Stuart Poulton is well-positioned to continue making a meaningful impact in the biopharmaceutical sector. As the Executive Vice President and Chief Development Officer at Karyopharm Therapeutics Inc., he is poised to lead the company's clinical development efforts and contribute to the advancement of transformative therapies that improve patient lives.
